Business Description
NGM Biopharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US62921N1054
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 104.41 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.98 | |||||
Beneish M-Score | -6.06 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -65.2 | |||||
3-Year EBITDA Growth Rate | -8.4 | |||||
3-Year EPS without NRI Growth Rate | -4.9 | |||||
3-Year FCF Growth Rate | -9.1 | |||||
3-Year Book Growth Rate | -23.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.43 | |||||
9-Day RSI | 43.66 | |||||
14-Day RSI | 48.54 | |||||
6-1 Month Momentum % | 19.53 | |||||
12-1 Month Momentum % | -60.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.79 | |||||
Quick Ratio | 7.79 | |||||
Cash Ratio | 7.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | 3.57 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3429.09 | |||||
Net Margin % | -3223.34 | |||||
FCF Margin % | -3021.37 | |||||
ROE % | -71.83 | |||||
ROA % | -62.02 | |||||
ROIC % | -605.18 | |||||
ROC (Joel Greenblatt) % | -1728.12 | |||||
ROCE % | -76.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 29.06 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 0.86 | |||||
EV-to-EBIT | 0.24 | |||||
EV-to-EBITDA | 0.24 | |||||
EV-to-Revenue | -8.18 | |||||
EV-to-FCF | 0.27 | |||||
Price-to-Net-Current-Asset-Value | 0.94 | |||||
Price-to-Net-Cash | 1.03 | |||||
Earnings Yield (Greenblatt) % | 416.67 | |||||
FCF Yield % | -103.83 |